Yasser Perera

This study evaluates two synthetic adjuvants, ODN-39M and LALF32-51, for enhancing immune response against Mycobacterium tuberculosis Ag85B via nasal vaccination in mice, showing ODN-39M's effectiveness in inducing Th1 and mucosal immunity.

This study evaluates two nasal coronavirus vaccines in African Green Monkeys, showing they induce cross-reactive immunity and neutralizing responses against SARS-CoV-2 and related coronaviruses.

This paper evaluates a nasal SARS-CoV-2 vaccine candidate based on S2 and N proteins, showing broad antibody responses and mucosal immunity in mice.

This study examines the time- and dose-dependent effects of CIGB-300 on the proteome of squamous lung cancer cells, identifying potential biomarkers and mechanisms of action.

This study investigates CK2 subunit deregulation in NSCLC using multiomics data and IHC, finding that CSNK2A1 and CSNK2B upregulation correlates with poor prognosis and tumor progression.

This study shows that CIGB-300 reverses multidrug resistance in ABCB1-overexpressing lung cancer cells by inhibiting ABCB1 expression and related signaling pathways.

This study uses computational biology to investigate how CIGB-300, a CK2 kinase antagonist, may interfere with SARS-CoV-2 infection and related pathologies.